AU2022280757B2 — Tizanidine liquid preparation and use thereof
Assigned to SICHUAN CREDIT PHARMACEUTICAL CO Ltd · Expires 2025-02-06 · 1y expired
What this patent protects
A tizanidine liquid preparation and a use thereof in preparation of drugs for treating muscle spasm. The tizanidine liquid preparation comprises an active ingredient, EDTA disodium, and other pharmaceutical excipients, wherein the active ingredient is one or more of tizanidine or…
USPTO Abstract
A tizanidine liquid preparation and a use thereof in preparation of drugs for treating muscle spasm. The tizanidine liquid preparation comprises an active ingredient, EDTA disodium, and other pharmaceutical excipients, wherein the active ingredient is one or more of tizanidine or a pharmaceutically acceptable salt, solvate and hydrate thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.